SOX12 and hepatocellular carcinoma: Upregulated SOX12 remodeled the immunosuppressive microenvironment by promoting CCL22/CCR4‐mediated Treg recruitment and functional enhancement and inducing PD‐L1‐mediated immune evasion, facilitating HCC progression and metastasis.